studies of delayed hypersensitivity using microbial antigens and in vitro including lymphocyte transformation tests and measurements of b and t cells indicated that rpbc patients had an immune response comparable to that of breast cancer patients without evidence of rapid progression .
C0024262
lymphocyte transformation
C0301872
immune response